Gabriel Theron, CEO of Cilo Cybin Pharmaceutical, on the company's plans to list on the JSE.

Please remember to disable your adblocker to view content from our affiliates.

Cilo Cybin Pharmaceutical recently announced its plan to list on the JSE in the next 12 months. BizNews spoke to CEO Gabriel Theron to discuss the company’s future plans and the challenges that have been encountered in founding and establishing a company in what is still a controversial industry in South Africa.